244 related articles for article (PubMed ID: 15198122)
1. Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration.
Branchi I; Bichler Z; Minghetti L; Delabar JM; Malchiodi-Albedi F; Gonzalez MC; Chettouh Z; Nicolini A; Chabert C; Smith DJ; Rubin EM; Migliore-Samour D; Alleva E
J Neuropathol Exp Neurol; 2004 May; 63(5):429-40. PubMed ID: 15198122
[TBL] [Abstract][Full Text] [Related]
2. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
3. The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation.
Soppa U; Schumacher J; Florencio Ortiz V; Pasqualon T; Tejedor FJ; Becker W
Cell Cycle; 2014; 13(13):2084-100. PubMed ID: 24806449
[TBL] [Abstract][Full Text] [Related]
4. DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome.
Lepagnol-Bestel AM; Zvara A; Maussion G; Quignon F; Ngimbous B; Ramoz N; Imbeaud S; Loe-Mie Y; Benihoud K; Agier N; Salin PA; Cardona A; Khung-Savatovsky S; Kallunki P; Delabar JM; Puskas LG; Delacroix H; Aggerbeck L; Delezoide AL; Delattre O; Gorwood P; Moalic JM; Simonneau M
Hum Mol Genet; 2009 Apr; 18(8):1405-14. PubMed ID: 19218269
[TBL] [Abstract][Full Text] [Related]
5. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
[TBL] [Abstract][Full Text] [Related]
6. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.
Jung MS; Park JH; Ryu YS; Choi SH; Yoon SH; Kwen MY; Oh JY; Song WJ; Chung SH
J Biol Chem; 2011 Nov; 286(46):40401-12. PubMed ID: 21965663
[TBL] [Abstract][Full Text] [Related]
7. Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells.
Park J; Oh Y; Yoo L; Jung MS; Song WJ; Lee SH; Seo H; Chung KC
J Biol Chem; 2010 Oct; 285(41):31895-906. PubMed ID: 20696760
[TBL] [Abstract][Full Text] [Related]
8. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
Altafaj X; Dierssen M; Baamonde C; Martí E; Visa J; Guimerà J; Oset M; González JR; Flórez J; Fillat C; Estivill X
Hum Mol Genet; 2001 Sep; 10(18):1915-23. PubMed ID: 11555628
[TBL] [Abstract][Full Text] [Related]
10. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J
J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
[TBL] [Abstract][Full Text] [Related]
11. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.
Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M
Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome.
García-Cerro S; Martínez P; Vidal V; Corrales A; Flórez J; Vidal R; Rueda N; Arbonés ML; Martínez-Cué C
PLoS One; 2014; 9(9):e106572. PubMed ID: 25188425
[TBL] [Abstract][Full Text] [Related]
13. DYRK1A regulates Hap1-Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome.
Xiang J; Yang S; Xin N; Gaertig MA; Reeves RH; Li S; Li XJ
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1224-E1233. PubMed ID: 28137862
[TBL] [Abstract][Full Text] [Related]
14. DYRK1A BAC transgenic mouse: a new model of thyroid dysgenesis in Down syndrome.
Kariyawasam D; Rachdi L; Carré A; Martin M; Houlier M; Janel N; Delabar JM; Scharfmann R; Polak M
Endocrinology; 2015 Mar; 156(3):1171-80. PubMed ID: 25490145
[TBL] [Abstract][Full Text] [Related]
15. Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
Hille S; Dierck F; Kühl C; Sosna J; Adam-Klages S; Adam D; Lüllmann-Rauch R; Frey N; Kuhn C
Cardiovasc Res; 2016 Jun; 110(3):381-94. PubMed ID: 27056896
[TBL] [Abstract][Full Text] [Related]
16. The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.
Woods YL; Rena G; Morrice N; Barthel A; Becker W; Guo S; Unterman TG; Cohen P
Biochem J; 2001 May; 355(Pt 3):597-607. PubMed ID: 11311120
[TBL] [Abstract][Full Text] [Related]
17. Increased dosage of DYRK1A and brain volumetric alterations in a YAC model of partial trisomy 21.
Sebrié C; Chabert C; Ledru A; Guedj F; Po C; Smith DJ; Rubin E; Rivals I; Beloeil JC; Gillet B; Delabar JM
Anat Rec (Hoboken); 2008 Mar; 291(3):254-62. PubMed ID: 18231969
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/- mouse.
Benavides-Piccione R; Dierssen M; Ballesteros-Yáñez I; Martínez de Lagrán M; Arbonés ML; Fotaki V; DeFelipe J; Elston GN
Neurobiol Dis; 2005 Oct; 20(1):115-22. PubMed ID: 16137572
[TBL] [Abstract][Full Text] [Related]
19. DYRK1A overexpression decreases plasma lecithin:cholesterol acyltransferase activity and apolipoprotein A-I levels.
Tlili A; Noll C; Middendorp S; Duchon A; Jouan M; Benabou E; Hérault Y; Paul JL; Delabar JM; Janel N
Mol Genet Metab; 2013 Nov; 110(3):371-7. PubMed ID: 23920041
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome.
Hijazi M; Fillat C; Medina JM; Velasco A
Exp Neurol; 2013 Jan; 239():229-34. PubMed ID: 23124096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
